BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5064809)

  • 1. Oral contraceptives and anti-thrombin-3 activity: a new method of antithrombin estimation.
    Howie PW; Prentice CR; McNicol GP
    Clin Sci; 1972 Jul; 43(1):2P. PubMed ID: 5064809
    [No Abstract]   [Full Text] [Related]  

  • 2. A method of antithrombin estimation using plasma defibrinates with ancrod.
    Howie PW; Prentice CR; McNicol GP
    Br J Haematol; 1973 Jul; 25(1):101-10. PubMed ID: 4799764
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of depressed antithrombin-3 activity associated with oral contraceptives.
    Zuck TF; Bergin JJ; Raymond JM; Dwyre WR
    Surg Gynecol Obstet; 1971 Oct; 133(4):609-12. PubMed ID: 5096309
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and low antithrombin-3 activity.
    Wolf P
    Lancet; 1970 Jan; 1(7638):144. PubMed ID: 4188753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral contraceptives and antithrombin-3].
    Naess K
    Tidsskr Nor Laegeforen; 1971 Apr; 91(12):892. PubMed ID: 5554782
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Pill and antithrombin. Effects of the pill on progressive antithrombin activity and plasmatic concentration of 3 antithrombins].
    Marcel GA; Sabatier C; Casper C; Warniez C
    Nouv Presse Med; 1973 Nov; 2(42):2820-1. PubMed ID: 4773655
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Antithrombin 3 during use of oral contraceptives].
    Stein WW; Halberstadt E; Römer E
    Arch Gynakol; 1973 Sep; 214(1):264-5. PubMed ID: 4801447
    [No Abstract]   [Full Text] [Related]  

  • 11. Deciphering the coagulation profile through the dynamics of thrombin activity.
    de Laat-Kremers RMW; Yan Q; Ninivaggi M; de Maat M; de Laat B
    Sci Rep; 2020 Jul; 10(1):12544. PubMed ID: 32719370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin 3 and the estrogen content of combined estro-progestagen contraceptives.
    Conard J; Samama M; Salomon Y
    Lancet; 1972 Nov; 2(7787):1148-9. PubMed ID: 4117229
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin inhibitors in women on oral contraceptives.
    Guagnellini E; Bertolini G; Cappelletti M; Colombo G
    Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.
    Howie PW; Mallinson AC; Prentice CR; Horne CH; McNicol GP
    Lancet; 1970 Dec; 2(7687):1329-32. PubMed ID: 4098907
    [No Abstract]   [Full Text] [Related]  

  • 15. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of blood coagulation parameters.
    Newman RL; Sirridge M; Brinkman M; Shannon R
    Am J Obstet Gynecol; 1976 May; 125(1):108-14. PubMed ID: 775991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?].
    Fagerhol MK; Abildgaard U
    Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1559-60. PubMed ID: 5457809
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of immunochemical and biological properties of human anti thrombin during blood clotting and upon interaction with exogenous thrombin.
    Esnard F; Gauthier F; Mouray H
    Thromb Res; 1983 Jul; 31(1):127-33. PubMed ID: 6612691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical hypercoagulability and oral contraceptives.
    von Kaulla E; von Kaulla KN; Droegemueller W
    Rocky Mt Med J; 1972 Jun; 69(6):33-6. PubMed ID: 5031944
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.
    Fagerhol MK; Abildgaard U
    Scand J Haematol; 1970; 7(1):10-7. PubMed ID: 4988538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.